Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.

Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87

Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS). PLoS One (2017) 0.75

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25

Endothelial function and dysfunction: testing and clinical relevance. Circulation (2007) 6.47

Role of endothelial dysfunction in atherosclerosis. Circulation (2004) 5.77

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54

The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med (2005) 4.76

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care (2004) 3.87

Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76

Global epidemiology of areca nut usage. Addict Biol (2002) 3.15

Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol (2006) 2.51

The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol (2012) 2.44

LDL cholesterol in CKD--to treat or not to treat? Kidney Int (2013) 2.17

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14

Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis (2000) 2.05

Familial clustering of chronic kidney disease. Semin Dial (2007) 1.95

Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev (2006) 1.66

Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens (2003) 1.58

Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol (1998) 1.54

Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD. Am J Kidney Dis (2011) 1.48

Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet (1997) 1.42

A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol (1988) 1.41

Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study. J Am Soc Nephrol (2007) 1.40

Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens (2013) 1.29

Neurological aspects of areca and betel chewing. Addict Biol (2002) 1.19

Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. Am J Kidney Dis (1998) 1.07

Betel-quid use is associated with the risk of the metabolic syndrome in adults. Am J Clin Nutr (2006) 1.04

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.01

Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in hispanic families with a hypertensive proband. Circulation (2001) 0.99

Areca nut chewing and systemic inflammation: evidence of a common pathway for systemic diseases. J Inflamm (Lond) (2012) 0.92

Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts. Mutat Res (2006) 0.91

Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients. Am J Kidney Dis (2010) 0.91

A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS). Am J Kidney Dis (2008) 0.89

Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis (2002) 0.88

Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities. Am J Kidney Dis (2009) 0.85

Chewing betel quid and the risk of metabolic disease, cardiovascular disease, and all-cause mortality: a meta-analysis. PLoS One (2013) 0.83

Prevalence of family history of kidney disease and perception of risk for kidney disease: a population-based study. Am J Kidney Dis (2005) 0.82

Obesity is associated with family history of ESRD in incident dialysis patients. Am J Kidney Dis (2006) 0.80

Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China. BMC Nephrol (2013) 0.76

Association of dialysis with the risks of cancers. PLoS One (2015) 0.81

Save life and improve quality: report from the 5th Congress of International Society for Hemodialysis. Hemodial Int (2013) 0.78

Nonapnea Sleep Disorders in Patients Younger than 65 Years Are Significantly Associated with CKD: A Nationwide Population-Based Study. PLoS One (2015) 0.77

Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort. Am J Hypertens (2014) 0.77

P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease. PLoS One (2014) 0.75

Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients. Nephrol Dial Transplant (2016) 0.75